Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
Article in ESMO Open (November 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Challenges of Investigator-initiated Clinical Trials to Support the New Drug Development
Article in Chinese Journal of Lung Cancer (July 2022)